Scilex Holding Company Debt Instrument Issued Principal
Scilex Holding Company (SCLX) reported Debt Instrument Issued Principal of $25.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Financial Statements › Notes
us-gaap:DebtInstrumentIssuedPrincipal · last filed 2025-03-31
- Scilex Holding Company debt instrument issued principal for the quarter ending 2023-09-30 was $0.00.
| Period end | Debt Instrument Issued Principal | Debt Instrument Issued Principal 3 month | Debt Instrument Issued Principal 6 month | Debt Instrument Issued Principal 9 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $25.00M 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | $25.00M 10-Q · filed 2023-08-11 | |||
| 2023-04-30 | $25.00M 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |